Evidence map›Paper›PMID 30883590›Full record

ArticlePloS one2019

Color-coded molecular beacons for multiplex PCR screening assays.

Salvatore A E Marras, Sanjay Tyagi, Dan-Oscar Antson, Fred Russell Kramer

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Salvatore A E MarrasPublic Health Research Institute, Department of Microbiology, Biochemistry and Molecular Genetics, New Jersey Medical School, Rutgers University, Newark, New Jersey, United States of America.
Sanjay TyagiPublic Health Research Institute, Department of Medicine, New Jersey Medical School, Rutgers University, Newark, New Jersey, United States of America.
Dan-Oscar AntsonCenter for Technology Licensing, Weill Cornell Medical Center, Cornell University, New York, New York, United States of America.ORCID 0000-0002-5473-6377
Fred Russell KramerPublic Health Research Institute, Department of Microbiology, Biochemistry and Molecular Genetics, New Jersey Medical School, Rutgers University, Newark, New Jersey, United States of America.ORCID 0000-0002-7471-831X
Rutgers, The State University of New Jersey · USCornell University · US

Funding

Background free amplified single-molecule FISH for in situ and flow cytometric applicationsR01CA227291 · NCI · RBHS-NEW JERSEY MEDICAL SCHOOL · PI TYAGI, SANJAY · 2018 to 2022
$2.8M
MOLECULAR BEACONS FOR RETROVIRAL DIAGNOSTICSR01EB000277 · NIBIB · PUBLIC HEALTH RESEARCH INSTITUTE · PI KRAMER, FRED R · 2002 to 2004
$1.8M
NCI NIH HHS R01 CA227291NIBIB NIH HHS R01 EB000277
6 · The paper itself

Abstract

The number of different fluorescent colors that can be distinguished in a PCR screening assay restricts the number of different targets that can be detected. If only six colors can be distinguished, and the probe for each target is labeled with a unique color, then only six different targets can be identified. Yet, it is often desirable to identify more targets. For instance, the rapid identification of which bacterial species (if any) is present in a patient's normally sterile blood sample, out of a long list of species, would enable appropriate actions to be taken to prevent sepsis. We realized that the number of different targets that can be identified in a screening assay can be increased significantly by utilizing a unique combination of two colors for the identification of each target species. We prepared a demonstration assay in which 15 different molecular beacon probe pairs were present, each pair specific for the same identifying sequence in the 16S ribosomal RNA gene of a different bacterial species, and each pair labeled with a unique combination of two fluorophores out of the six differently colored fluorophores that our PCR instrument could distinguish. In a set of PCR assays, each containing all 30 color-coded molecular beacons, and each containing DNA from a different bacterial species, the only two colors that arose in each real-time assay identified the species-specific target sequence that was present. Due to the intrinsic low background of molecular beacon probes, these reactions were specific and extremely sensitive, and the threshold cycle reflected the abundance of the target sequence present in each sample.

Indexed as

BacteriaBacterial InfectionsColorFluorescent DyesGenes, BacterialHumansMass ScreeningMolecular ProbesMultiplex Polymerase Chain ReactionRNA, Ribosomal, 16SSepsisSpecies SpecificityFluorescent DyesMolecular ProbesRNA, Ribosomal, 16S

Identifiers

PMID30883590
PMCPMC6422326
OpenAlexW2921505876

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.